Decheng Capital LLC Top Holdings and 13F Report (2025) About Decheng Capital LLCInvestment ActivityDecheng Capital LLC has $356.49 million in total holdings as of March 31, 2025.Decheng Capital LLC owns shares of 27 different stocks, but just 7 companies or ETFs make up 80% of its holdings.Approximately 9.11% of the portfolio was purchased this quarter.About 6.41% of the portfolio was sold this quarter.This quarter, Decheng Capital LLC has purchased 28 new stocks and bought additional shares in 2 stocks.Decheng Capital LLC sold shares of 8 stocks and completely divested from 2 stocks this quarter.Largest Holdings CG ONCOLOGY INC $156,042,173Nuvation Bio $45,679,813AARDVARK THERAPEUTICS INC $29,418,915Upstream Bio Inc. $20,105,993NewAmsterdam Pharma $15,761,900 Largest New Holdings this Quarter 002942100 - AARDVARK THERAPEUTICS INC $29,418,915 Holding Largest Purchases this Quarter AARDVARK THERAPEUTICS INC 3,917,299 shares (about $29.42M)Aclaris Therapeutics 1,775,069 shares (about $2.72M)Crinetics Pharmaceuticals 10,000 shares (about $335.40K) Largest Sales this Quarter Illumina 83,018 shares (about $6.59M)Arcellx 34,377 shares (about $2.26M)Krystal Biotech 11,772 shares (about $2.12M)BioNTech 20,000 shares (about $1.82M)Legend Biotech 53,558 shares (about $1.82M) Sector Allocation Over TimeMap of 500 Largest Holdings ofDecheng Capital LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorCG ONCOLOGY INC$156,042,1730.0%6,371,66943.8%COMNUVBNuvation Bio$45,679,8130.0%25,954,43912.8%MedicalAARDVARK THERAPEUTICS INC$29,418,915$29,418,915 ▲New Holding3,917,2998.3%COMUpstream Bio Inc.$20,105,9930.0%3,285,2935.6%COMNAMSNewAmsterdam Pharma$15,761,9000.0%770,0004.4%MedicalKRYSKrystal Biotech$11,719,500$2,122,492 ▼-15.3%65,0003.3%MedicalRVMDRevolution Medicines$7,991,3600.0%226,0002.2%MedicalMRUSMerus$7,959,1350.0%189,0982.2%MedicalBYSIBeyondSpring$6,971,6040.0%4,882,6512.0%MedicalMOONLAKE IMMUNOTHERAPEUTICS$6,704,4120.0%171,6001.9%COMLYELLyell Immunopharma$6,407,2250.0%11,909,3411.8%MedicalRCUSArcus Biosciences$6,348,9940.0%808,7891.8%MedicalACRSAclaris Therapeutics$6,183,856$2,715,856 ▲78.3%4,041,7361.7%MedicalCRNXCrinetics Pharmaceuticals$5,968,711$335,400 ▲6.0%177,9581.7%MedicalCYTKCytokinetics$4,019,0000.0%100,0001.1%MedicalLEGNLegend Biotech$3,393,000$1,817,223 ▼-34.9%100,0001.0%MedicalACLXArcellx$3,280,000$2,255,131 ▼-40.7%50,0000.9%MedicalZNTLZentalis Pharmaceuticals$3,211,422$506,150 ▼-13.6%2,019,7620.9%MedicalAURAAura Biosciences$3,021,1520.0%515,5550.8%MedicalBNTXBioNTech$1,821,200$1,821,200 ▼-50.0%20,0000.5%MedicalEQEquillium$1,744,6790.0%4,447,3080.5%MedicalFDMT4D Molecular Therapeutics$1,083,713$208,286 ▼-16.1%335,5150.3%MedicalILMNIllumina$932,166$6,586,651 ▼-87.6%11,7490.3%MedicalPYXSPyxis Oncology$320,2410.0%326,8100.1%MedicalGRAIL INC$247,3290.0%9,6840.1%COMVERAVera Therapeutics$107,970$1,087,434 ▼-91.0%4,4950.0%MedicalNuvation Bio Inc.$43,9900.0%646,0570.0%WARRANTSPHATPhathom Pharmaceuticals$0$5,637,342 ▼-100.0%00.0%MedicalATRCAtriCure$0$818,916 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
